↩ Go Back
Need help?

Generic Pharmaceuticals Company Investment Opportunity in Hyderabad, India

Pain management novel drugs having 6 categories and an established network with 9,000 doctors.

Established 5-10 year(s)
Employees 50 - 100
Legal Entity Private Limited Company
Reported Sales USD 24 thousand
Run Rate Sales USD 650 thousand
EBITDA Margin Nil
Industries Generic Pharmaceuticals
Locations  Hyderabad
Local Time 1:50 PM Asia / Kolkata
Listed By Business Owner / Director
Status Active
Overall Rating
Partial Stake Sale
USD 240 thousand for 15.0% stake (Native Currency: INR 20,000,000)
Reason: To expand our presence in other cities by increasing tie-ups with doctors and hospitals.
Includes physical assets worth USD 11 thousand
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Documents
Business Overview

Company is in partnership with a pharma manufacturing company to sell 6 novelty pain management drugs across India. Have established our network with more than 9,000 doctors and growing. Our revenue was low for the first 8-9 months and now with our good relationship with doctors, we have been able to reach multiple hospitals and clinics. In last 3 months we have already crossed INR 1.5 crore of revenue. We project the same growth rate for the future and are seeking funds to increase our presence in other cities.

Director of the company has 25 years of experience. We aim to reach break even in next 4-5 months. Company owned assets include computers, laptops and furniture.

Products & Services Overview

Pain management drugs having 6 category of products in the market under own brand name.

Facilities Overview

1,675 sq ft of office on rent.

Capitalization Overview
Not Disclosed
Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

4 Investors viewed this Business this month.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more